HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jaw-Wen Chen Selected Research

Fatty Acid-Binding Proteins

12/2020Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis.
1/2020Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease.
3/2019Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease.
1/2018The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jaw-Wen Chen Research Topics

Disease

42Atherosclerosis
01/2023 - 01/2002
34Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 08/2003
32Heart Failure
12/2023 - 08/2003
32Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 07/2002
31Inflammation (Inflammations)
05/2024 - 05/2003
27Hypertension (High Blood Pressure)
01/2022 - 04/2004
26Myocardial Infarction
03/2023 - 01/2007
21Ischemic Stroke
12/2021 - 01/2007
18Ischemia
08/2023 - 08/2009
16Diabetes Mellitus
10/2023 - 04/2010
12Chronic Renal Insufficiency
08/2023 - 05/2011
11Stroke (Strokes)
05/2024 - 03/2013
11Type 2 Diabetes Mellitus (MODY)
01/2023 - 11/2009
10Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 07/2004
7Hyperplasia
01/2023 - 01/2002
7Coronary Disease (Coronary Heart Disease)
10/2022 - 03/2010
7Hyperglycemia
08/2022 - 01/2005
6Kidney Diseases (Kidney Disease)
10/2023 - 01/2013
6Fibrosis (Cirrhosis)
08/2023 - 03/2013
6Disease Progression
07/2022 - 03/2006
6Diabetic Nephropathies (Diabetic Nephropathy)
07/2022 - 08/2014
6Insulin Resistance
01/2021 - 01/2013
6Hypercholesterolemia
03/2020 - 12/2004
5Hypertrophy
05/2023 - 08/2014
5Pathologic Constriction (Stenosis)
07/2022 - 04/2004
5Atrial Fibrillation
12/2020 - 04/2012
5Neoplasms (Cancer)
03/2014 - 04/2011
5Essential Hypertension
10/2011 - 11/2009
4Death (Near-Death Experience)
12/2023 - 03/2011
4Acute Kidney Injury (Acute Renal Failure)
08/2023 - 07/2013
4Abdominal Aortic Aneurysm
04/2023 - 12/2013
4Heart Arrest (Cardiac Arrest)
03/2023 - 03/2017
4Vascular Diseases (Vascular Disease)
11/2022 - 02/2007
4Acute Coronary Syndrome
07/2021 - 01/2013
4Chronic Kidney Failure (Chronic Renal Failure)
01/2021 - 03/2013
4Thrombosis (Thrombus)
04/2016 - 10/2005
3Infections
05/2024 - 08/2017
3Vascular System Injuries
01/2023 - 12/2007
3Wounds and Injuries (Trauma)
08/2022 - 08/2006
3Non-alcoholic Fatty Liver Disease
07/2022 - 12/2010
3Cardiomyopathies (Cardiomyopathy)
01/2021 - 05/2017
3Atherosclerotic Plaque (Atheroma)
09/2020 - 01/2002
3Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 10/2011
3Obesity
01/2020 - 03/2014

Drug/Important Bio-Agent (IBA)

22LipidsIBA
12/2021 - 06/2002
21omega-Chloroacetophenone (Mace)IBA
12/2023 - 12/2008
20erucylphosphocholineIBA
01/2023 - 06/2007
17C-Reactive ProteinIBA
11/2023 - 05/2004
16Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 09/2005
15Biomarkers (Surrogate Marker)IBA
05/2024 - 10/2004
14Glucose (Dextrose)FDA LinkGeneric
05/2023 - 07/2004
12AdiponectinIBA
11/2023 - 12/2009
11oxidized low density lipoproteinIBA
07/2021 - 12/2005
11AntioxidantsIBA
07/2016 - 01/2002
9CholesterolIBA
01/2020 - 01/2002
8CytokinesIBA
01/2023 - 09/2003
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 08/2009
8LigandsIBA
01/2023 - 12/2006
8Proteins (Proteins, Gene)FDA Link
09/2020 - 06/2009
8Matrix Metalloproteinases (MMPs)IBA
01/2019 - 12/2007
7Reactive Oxygen Species (Oxygen Radicals)IBA
05/2024 - 09/2003
7Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2023 - 09/2005
7Streptozocin (Streptozotocin)FDA Link
08/2022 - 08/2012
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 01/2002
7Triglycerides (Triacylglycerol)IBA
04/2017 - 07/2004
6NADPH Oxidases (NAD(P)H oxidase)IBA
08/2023 - 12/2006
6Heme Oxygenase-1IBA
07/2022 - 07/2002
6Ginkgo biloba extract (Rokan)IBA
02/2021 - 01/2002
6BilirubinIBA
01/2019 - 08/2008
5Hydralazine (Apresoline)FDA LinkGeneric
08/2023 - 01/2015
5CC ChemokinesIBA
08/2022 - 01/2016
5Angiotensin Receptor AntagonistsIBA
12/2021 - 12/2006
5Fenofibrate (CiL)FDA LinkGeneric
01/2021 - 05/2013
5Insulin (Novolin)FDA Link
01/2020 - 01/2005
4Interleukin-6 (Interleukin 6)IBA
11/2023 - 05/2012
4CalciumIBA
07/2022 - 08/2005
4AlbuminsIBA
07/2022 - 08/2010
4Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
01/2022 - 08/2014
4Fatty Acid-Binding ProteinsIBA
12/2020 - 01/2018
4NF-kappa B (NF-kB)IBA
09/2020 - 01/2002
4LDL CholesterolIBA
08/2020 - 01/2013
4pro-brain natriuretic peptide (1-76)IBA
01/2020 - 08/2007
4ThiazidesIBA
01/2016 - 12/2009
4Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2013 - 11/2004
4Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2013 - 11/2002
3ChemokinesIBA
10/2023 - 04/2020
3Xanthine OxidaseIBA
08/2023 - 05/2017
3Angiotensin IIIBA
04/2023 - 12/2013
3trimethyloxamine (trimethylamine N-oxide)IBA
01/2023 - 12/2019
3Uric Acid (Urate)IBA
07/2022 - 02/2018
3HDL CholesterolIBA
12/2020 - 01/2012
3Matrix Metalloproteinase 2 (Gelatinase A)IBA
09/2020 - 12/2007
3Blood Glucose (Blood Sugar)IBA
01/2020 - 01/2005
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2020 - 08/2007

Therapy/Procedure

16Percutaneous Coronary Intervention
12/2023 - 01/2007
14Therapeutics
04/2017 - 04/2004
8Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2017 - 01/2007
6Renal Dialysis (Hemodialysis)
01/2020 - 01/2009
4Heart Transplantation (Grafting, Heart)
01/2012 - 08/2003
3Resuscitation
03/2023 - 12/2020